Neurocrine Biosciences, Inc. (NBIX)
128.63
-1.47
(-1.13%)
USD |
NASDAQ |
Feb 20, 16:00
128.61
-0.02
(-0.02%)
After-Hours: 20:00
Neurocrine Biosciences Shareholders Equity (Quarterly) : 3.253B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Glaukos Corp. | 656.16M |
| Edgewise Therapeutics, Inc. | 558.65M |
| Nuvalent, Inc. | 845.40M |
| Marker Therapeutics, Inc. | 18.39M |
| CapsoVision, Inc. | 20.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.753B |
| Total Liabilities (Quarterly) | 1.500B |
| Debt to Equity Ratio | 0.1449 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.26% |